00:52 , Jan 11, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Hepatitis C virus (HCV) Cell culture studies identified cajanine and its analogs as CSGALNACT1 inhibitors that could treat HCV infection. A human hepatoma cell line-based mRNA assay identified cajanine as an inhibitor of CSGALNACT1....